Moleculin Biotech Inc. Common Stock is a clinical-stage pharmaceutical company that develops novel anticancer and antiviral treatments. With a focus on creating breakthrough therapies that target difficult-to-treat tumors, Moleculin Biotech is at the forefront of innovation in the biotech industry.
